Stockhead on MSN
Health Check: Telix jumps first hurdle with its advanced prostate cancer therapy trial
In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...
Artificial intelligence has bounded into the mainstream, into personal lives, classroom assignments and work meetings — so it should be no surprise to find it in doctors’ offices and emergency ...
Safer Minimally Invasive Treatments in High-Risk & Comorbid Patients with Prostate Enlargement (BPH)
Prostate enlargement, which is called Benign Prostatic Hyperplasia (BPH) is a non-cancerous enlargement and is common in ...
Men are almost 60 per cent more likely than women to die before the age of 75, according to government figures. One doctor ...
Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...
Calgary Herald on MSN
Prostate Cancer Centre teams up with Bret Hart to help take down scourge
For the seventh year in a row, fans of Bret Hart will get a chance to meet the legendary wrestler on Saturday at Sunridge ...
Lancs Live on MSN
Doctor warns men to stop doing 3 things to avoid heart attacks, cancer, and strokes
A doctor has shared three things all men should stop doing to protect their long-term health, warning that ignoring these ...
If I could get every adult, especially women entering midlife, to know just five things about their family tree, it would ...
A British surgeon successfully removed a prostate from a cancer patient in Gibraltar while operating from London using a four-armed robotic system. The groundbreaking telesurgery connected the two ...
Across the UK, pub bells will ring early for the final time this Wednesday as part of a new campaign by Greene King and ...
India has the highest number of renal patients in the world, with 10 per cent of Indian population being affected by Chronic Kidney Disease (CKD) and it may soon be 5th leading cause of death in India ...
Stockhead on MSN
Health Check: Rhythm Biosciences is in the groove with first commercial sale of its bowel cancer assay
Rhythm Biosciences is entering a new commercial era, following the first sale of its revolutionary Colostat bowel cancer assay. ... Read More The post Health Check: Rhythm Biosciences is in the groove ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results